据Business Insider：Anthropic员工或因罢工计划转为远程办公。

Caitong Fuxin Fixed-Open Mixed Fund will be suspended from the afternoon session open on 25 August 2026 through market close that day.

China's National Medical Products Administration held an expanded bureau meeting and announced regulatory steps to speed commercialization and tighten safety oversight. The NMPA ordered a shift to a prevention‑oriented regulatory model with deeper risk consultations and expanded social co‑governance to curb safety risks in key areas. It will establish a service-plus-review-and-approval mechanism to accelerate R&D translation, explicitly supporting high‑quality generics and strengthening drug access for special populations while expanding high‑level external openness. The agency also directed upgrades to regulatory capacity — implementing plans, enhancing technical supervision, accelerating talent development and smart regulation — and launched a Clean Drug Regulation rectification to strengthen oversight and accountability.